Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General microbial cell components refer to a diverse group of structural and functional molecules essential for the survival, replication, and virulence of bacteria, fungi, viruses, and parasites. These include the bacterial cell wall (peptidoglycan), fungal cell wall (chitin and glucans), cell membranes (ergosterol in fungi), ribosomes, and nucleic acids, as well as Pathogen-Associated Molecular Patterns (PAMPs) like lipopolysaccharides (LPS) [1][2]. In pharmacology, these components are the primary targets for anti-infective therapy, where drugs exploit the biochemical differences between microbial and host cells to achieve selective toxicity [3]. For example, beta-lactam antibiotics interfere with peptidoglycan cross-linking, while polyenes bind to fungal ergosterol to disrupt membrane integrity [4]. Because this term encompasses a heterogeneous collection of molecules rather than a single defined protein or receptor, it is considered a non-specific or high-level classification in therapeutic contexts [5]. [1] Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002. [2] Silhavy TJ, et al. The bacterial cell envelope. Cold Spring Harb Perspect Biol. 2010. [3] Kohanski MA, et al. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 2007. [4] Odds FC, et al. Antifungal agents: mechanisms of action. Trends Microbiol. 2003. [5] Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature. 2000.
Inhibition of cell wall synthesis, disruption of cell membrane integrity, inhibition of protein synthesis, and inhibition of nucleic acid replication.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General microbial cell components.